Disease | renal cell carcinoma |
Phenotype | C0025202|melanoma |
Sentences | 2 |
PubMedID- 25892889 | Although ipilimumab has been shown to improve survival in patients with metastatic melanoma and cause regression of metastatic renal cell carcinoma, the associated immune-related toxicities are of concern. |
PubMedID- 23734338 | Several studies indicate indeed that the therapeutic effects of oncolytic viruses depend, at least in part, from the elicitation of tumor-specific immune responses.12 in this sense, melanoma (together with renal cell carcinoma) surely constitutes a relatively privileged setting. |
Page: 1